Major Shareholders

As of 30th September 2008, the issued share capital of FuturaGene plc is 42,736,798 ordinary shares of £0.005p each.

As of that date the number of shares not in public hands as defined in the AIM rules was, in aggregate 7,325,117, representing 17.1% of the issued share capital.

Holdings of major shareholders, as registered on 30th September 2008, are listed below:

• Pershing Keen Nominees Limited A/c LSCLT(12.5%)
• Pershing Keen Nominees Limited A/c PSL981(22.1%)
• BNY Mellon Nominees Limited (6.1%)
• Clachan Nominees Limited (5.7%)
• HSBC Global Custody (12.7%)
• Monument Capital LLC (5.8%)
• M.A. Pritchard (5.6%)
• B. Anderson ( 5.6%)